Deerfield Management Company LP Series C

Deerfield Management Company LP Series C, a Delaware-based limited partnership, operates with 125 employees, 96 of whom are advisors, and its client base remains unknown. It was last authorized by the SEC on March 30, 2012, and its registration status shows as "approved."

• DAVID JUSTUS CLARK

  GENERAL COUNSEL owns less than 5%

• FLYNN MANAGEMENT LLC

  GENERAL PARTNER owns 75% or more

• JAMES EDWARD FLYNN

  PRESIDENT owns less than 5%

• JONATHAN DAVID ISLER

  CHIEF FINANCIAL OFFICER owns less than 5%

• KAREN ARNONE NOY

  CHIEF ADMINISTRATIVE OFFICER owns less than 5%

• MARIAN LYIA BRANCACCIO

  CHIEF COMPLIANCE OFFICER owns less than 5%

• JAMES EDWARD FLYNN

  SOLE MEMBER owns 75% or more

• GOLDMAN SACHS & CO. LLC
  United States
• MORGAN STANLEY & CO. LLC
  United States
• NATIONAL FINANCIAL SERVICES LLC
  United States

• Advantage Advisers Multi-Manager LLC
• Audax Management Company NY LLC
• Weiss Multi-Strategy Advisers LLC
• Morgan Stanley Real Estate Advisor Inc
• Mazars USA Wealth Advisors LLC
• Safran Wealth Advisors LLC
• Atalanta Sosnoff Capital LLC
• Encompass Capital Advisors LLC
• AIG Asset Management US LLC
• Broadwood Capital Inc

• Deerfield Management Company's Q3 2022 vs. Q4 2022 13F Holdings Comparison: Which Companies Experienced the Most Significant Changes?

• HORIZON THERAPEUTICS PLC $155,491k
• HORIZON PHARMA INVESTMENT LTD $150,514k
• MYLAN N V $142,121k
• ORCHARD THERAPEUTICS PLC $124,841k
• NEVRO CORP $120,607k
• Homology Medicines $112,730k
• AERIE PHARMACEUTICALS INC $89,625k
• Intersect ENT Inc. $70,761k
• IMMUNOMEDICS INC $69,147k
• Acceleron Pharma Inc $53,617k